BRIDGEWATER, N.J.–(BUSINESS WIRE)–Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that members
of management will participate at the following upcoming investor
conferences:
-
Goldman Sachs 40th Annual Global Healthcare Conference at
2:00 p.m. PT (5:00 p.m. ET) on June 12, 2019 in Rancho Palos Verdes,
CA. -
Raymond James Life Sciences & MedTech Conference at 3:00 p.m. ET on
June 19, 2019 in New York, NY.
To access a live webcast of the presentation, visit Amneal’s Investor
Relations Web site at https://investors.amneal.com.
The Goldman Sachs Conference webcast can also be accessed at the
following URL:
https://event.webcasts.com/starthere.jsp?ei=1249194&tp_key=29cffed06b&tp_special=8.
The Raymond James Conference webcast can also be accessed at the
following URL:
http://wsw.com/webcast/rj115/amrx/.
An archived version will be available approximately one hour after the
live presentation and can be accessed at the same location for 90 days.
About Amneal
Amneal Pharmaceuticals, Inc. (NYSE: AMRX), headquartered in Bridgewater,
NJ, is an integrated pharmaceutical company focused on developing,
manufacturing and distributing generic, brand and biosimilar products.
The Company has approximately 6,000 employees in its operations in North
America, Asia, and Europe, working together to bring high-quality
medicines to patients primarily within the United States.
Amneal is one of the largest and fastest growing generic pharmaceutical
manufacturers in the United States, with an expanding portfolio of
generic products to include complex dosage forms in a broad range of
therapeutic areas. The Company also markets a portfolio of branded
pharmaceutical products through its Specialty segment focused
principally on central nervous system disorders and parasitic
infections. For more information, visit www.amneal.com.
Contacts
Mark Donohue
(908) 409-6718